Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, Customer and CountryDublin, Oct. 16, 2026 (GLOBE ...
Identify cancer immunotherapy opportunities, pitfalls and companies poised to benefit, with CAR-T, checkpoint inhibitor and cytokine insights for confident investment decisions.Dublin, Oct. 15, 2026 ...
Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in ...
Children with relapsed leukemia and solid tumors increasingly survive because of a new generation of cancer immunotherapies — ...
This podcast feature a fireside chat between Dr Ira Mellman, PICI and Dr Axel Hoos, Former CEO, Scorpion Therapeutics from the 2026 Immuno-Oncology 360° conference. Drawing on Dr Mellman’s extensive ...
The] platform applies controlled shear stress and leverages tumor cells as a natural source of endogenous major ...
A new study reveals that the protein GSDMB enhances anti-PD-1 immunotherapy in bladder cancer by driving Sema7a-mediated ...
Ira Mellman, the new president of research at the Parker Institute for Cancer Immunotherapy, asks why so many drug developers are retreating from immune-modulating drugs, cell therapies and cancer ...
Oncolytics Biotech (TSX:ONC) develops immuno-oncology therapeutic solutions. Explore operations, sector trends and key FAQs.
What work are you leading in whole-body molecular imaging to help advance immuno-oncology drug development? One facet of my role in scientific partnering and strategy is working with molecular imaging ...
In July 2019, Pelotonia pledged $102,065,000 to The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James), with $65 million of that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results